Efficacy of Lavender Essential Oil Chest Wraps in Infants With Bronchiolitis
NCT ID: NCT06108648
Last Updated: 2025-03-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE4
400 participants
INTERVENTIONAL
2023-12-07
2026-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
NCT00144846
A Study of Hypertonic Saline for Infants Hospitalized With Bronchiolitis
NCT01488448
Nebulized 3% Hypertonic Saline Versus Normal Saline in Managing Children With Acute Bronchiolitis: A Randomized Controlled Trial
NCT07138625
Nebulized Hypertonic Saline for Bronchiolitis
NCT00619918
Nebulized 5% Hypertonic Saline for the Treatment of Bronchiolitis
NCT01016249
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lavender oil
Lavender chest wrap:
Before the first application pour 10-15 ml of lavender essential oil 10% evenly on the cotton cloth. Put the soaked cotton in the plastic bag, close it and put it to heat in two heating pads (2-5 minutes) so that the oil is distributed on all the fabric. Place the cotton cloth around the patient's chest. Cover the cotton cloth with a woolen fabric that is 2 cm larger than the cotton cloth.
Lavender essential oil 10%, diluted in 90% olive oil
Lavender chest wrap:
Before the first application pour 10-15 ml of lavender essential oil 10% evenly on the cotton cloth.
Put the soaked cotton in the plastic bag, close it and put it to heat in two heating pads (2-5 minutes) so that the oil is distributed on all the fabric. Place the cotton cloth around the patient's chest.
Cover the cotton cloth with a woolen fabric that is 2 cm larger than the cotton cloth.
Control
Standard care: supportive measures according to national standards.
Control
Standard care according to national standards.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lavender essential oil 10%, diluted in 90% olive oil
Lavender chest wrap:
Before the first application pour 10-15 ml of lavender essential oil 10% evenly on the cotton cloth.
Put the soaked cotton in the plastic bag, close it and put it to heat in two heating pads (2-5 minutes) so that the oil is distributed on all the fabric. Place the cotton cloth around the patient's chest.
Cover the cotton cloth with a woolen fabric that is 2 cm larger than the cotton cloth.
Control
Standard care according to national standards.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hospitalization.
* Written informed consent.
Exclusion Criteria
* More than 3 episodes of bronchiolitis.
* Critically ill infants who have an immediate need for intensive care unit (ICU) admission.
* Respiratory deterioration needing Continuous positive airway pressure (CPAP) or transfer to ICU during study enrollment.
* Atopic dermatitis, eczema or other skin lesions (particularly on the chest).
* Oncologic disease.
* Premature infants with mild bronchopulmonary dysplasia will not be excluded.
11 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Geneva
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fabiola Stollar
Attending Physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Klara Posfay-Barbe, MD, PhD
Role: STUDY_DIRECTOR
Children's' Hospital, University Hospital of Geneva, Switzerland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinique de pediatrie, HFR Fribourg - Hopital cantonal, Switzerland
Fribourg, , Switzerland
Children's' Hospital, University Hospital of Geneva, Switzerland
Geneva, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-01116
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.